University of Michigan Rogel Cancer Center — Ann Arbor, Michigan

Public research footprint of University of Michigan Rogel Cancer Center, compiled from the ClinicalTrials.gov public registry.

260

Registered studies

186

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Melanoma · Recurrent Melanoma · Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma · Locally Recurrent Laryngeal Squamous Cell Carcinoma

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03528642 — Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Michigan Rogel Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.